T3 (Liothyronine Sodium)

T3 Dragon Pharma — Overview

T3 Dragon Pharma is liothyronine sodium — triiodothyronine, the biologically active form of thyroid hormone — at 25 mcg per tablet, supplied in packs of 100 tabs. Unlike thyroxine (T4), which must be converted to T3 by peripheral deiodinases before becoming active, liothyronine binds thyroid hormone receptors directly and produces measurable metabolic effects within 48–72 hours of the first dose. This makes it the compound of choice when a fast, controllable, and titrable boost to basal metabolic rate is the goal.

In the context of performance and physique sport, T3 is used during aggressive cutting phases to raise the metabolic rate beyond what caloric restriction and training alone can achieve. At supraphysiologic doses it is catabolic to muscle tissue as well as fat, which is why every practical T3 protocol pairs it with an anabolic steroid base. steroidwarehouse.com carries Dragon Pharma's 25 mcg tablet format alongside the full stack support needed to run it correctly in a cutting cycle.

About the Compound: Liothyronine (T3)

The thyroid gland produces two iodinated hormones: thyroxine (T4) and triiodothyronine (T3). T4 is the storage and transport form — it circulates at higher concentration but has minimal direct receptor activity. Peripheral tissues convert T4 to T3 via type I and type II iodothyronine deiodinases (D1, D2), which remove one iodine atom from the outer ring. T3 binds thyroid hormone receptors (THRα and THRβ) with approximately four times higher affinity than T4, making it the metabolically active molecule responsible for nearly all thyroid hormone effects at the cellular level. Exogenous liothyronine bypasses the T4→T3 conversion step entirely and acts directly on receptors within hours.

• Direct THRα/THRβ agonism — T3 binds nuclear thyroid hormone receptors and drives transcription of genes governing mitochondrial biogenesis, uncoupling protein expression, and metabolic enzyme activity; the result is increased basal metabolic rate (BMR) — the body burns more calories at rest; the effect is dose-dependent and measurable within 48–72 hours of the first dose of exogenous T3
• Faster onset and shorter half-life than T4 — liothyronine has a plasma half-life of ~2.5 days vs ~7 days for thyroxine; this means dose adjustments take effect quickly, but also that missing doses or stopping abruptly produces a rapid drop in circulating T3 levels; both the speed of onset and the fast offset are pharmacokinetic features that set T3 apart from T4 in clinical and performance use
• Endogenous thyroid axis suppression — exogenous T3 provides negative feedback to the hypothalamic-pituitary-thyroid (HPT) axis, suppressing TSH secretion; reduced TSH leads to decreased endogenous T4 and T3 production from the thyroid gland; this suppression is reversible but requires a proper taper when the exogenous T3 course ends, to avoid rebound hypothyroidism during the recovery window
• Dose-dependent shift from fat loss to catabolism — at physiologic-to-mildly supraphysiologic doses (25–50 mcg/day), T3 preferentially accelerates fat oxidation; as dose increases toward 75–100 mcg/day, the catabolic effect on skeletal muscle protein becomes significant; this is the central risk of T3 use in performance contexts and the reason an anabolic steroid base is not optional when running T3 above 50 mcg/day
• Rapid titration via 25 mcg increments — the 25 mcg tablet format allows precise dose escalation from a conservative starting point; most users begin at 25 mcg/day and increase by 25 mcg every 3–5 days based on thermogenic response and resting heart rate; this gradual approach minimizes side effects and allows individual response calibration before reaching higher doses

What T3 Does

Thyroid hormone regulates the speed of almost every cellular metabolic process. T3 increases oxygen consumption in nearly all tissues except the brain, testis, and spleen; it upregulates mitochondrial uncoupling proteins (UCPs) that release stored energy as heat rather than ATP; and it drives transcription of lipid oxidation enzymes that accelerate fatty acid mobilization and oxidation. In a caloric deficit with an adequate anabolic steroid base, these mechanisms translate into accelerated fat loss without disproportionate lean tissue loss.

• Elevated basal metabolic rate — T3 upregulates mitochondrial activity and increases the number and size of mitochondria in metabolically active tissue; resting caloric expenditure increases measurably within days of reaching an effective dose; the thermogenic effect is sustainable across the 4–8 week cycle duration without receptor downregulation, which distinguishes T3 from catecholamine-based thermogenics like clenbuterol that lose potency through beta-2 receptor desensitization
• Accelerated fat oxidation — T3 increases transcription of fatty acid oxidation enzymes and sensitizes adipocytes to lipolytic signals; in a caloric deficit this produces a measurable shift toward fat as the primary fuel source; users consistently report faster fat loss at the same caloric intake when T3 is added vs diet-and-cardio alone, particularly for loss of stubborn subcutaneous body fat in the lower abdominal and hip regions
• Increased glucose and macronutrient turnover — T3 accelerates both glucose oxidation and gluconeogenesis; dietary carbohydrates are metabolized faster, which supports energy levels in a caloric deficit but also means glycogen stores replenish and deplete more rapidly; some users find their capacity for high-intensity training improves during T3 cycles due to faster substrate availability between sessions
• Protein turnover acceleration (dose-dependent risk) — at supraphysiologic doses T3 increases the rate of both protein synthesis and protein degradation; net protein balance tips toward catabolism if anabolic signaling from androgens is insufficient to counter the catabolic drive; this is why T3 is not used as a standalone fat loss tool: without an AAS base maintaining muscle protein synthesis, lean mass losses during aggressive T3 cuts are significant and can offset the physique goal entirely
• Cardiovascular output increase — T3 increases heart rate, cardiac contractility, and cardiac output via THRα-mediated gene expression in cardiomyocytes; at therapeutic doses this is a physiologic response; at supraphysiologic doses (particularly above 75 mcg/day) persistent tachycardia and increased myocardial oxygen demand can become a meaningful cardiovascular stress, especially when combined with stimulant-based compounds like clenbuterol

Who It's For

• What sets T3 apart: among the fat loss compounds available at Steroid Warehouse, T3 operates through an entirely different mechanism than beta-2 agonists (Clenbuterol, Helios) or adrenergic/lipolytic blends. Clenbuterol desensitizes its receptors within 2 weeks and requires ketotifen cycling to sustain its effect. T3 works through nuclear receptor transcription and does not downregulate over a standard 4–8 week cycle. The metabolic rate increase from T3 is sustained throughout the cycle duration and is additive rather than synergistic when combined with clenbuterol — each compound operates through an independent pathway.
• Best scenario: competitive bodybuilders in the final 6–10 weeks of contest prep who need to accelerate fat loss beyond what caloric restriction and cardio alone can achieve; athletes who have already maximized their diet and training but need additional metabolic output to reach stage-ready conditioning; intermediate to advanced users running a cutting AAS stack who can protect muscle mass with adequate androgen levels; users who have plateaued on clenbuterol and want to add a mechanistically distinct thermogenic agent
• Choose something else instead: beginners and first-time steroid users should not add T3 without an established AAS base — the catabolic risk at effective T3 doses is too high without adequate androgen protection; anyone not running an AAS base during a cut should start with a non-catabolic option like Clenbuterol Dragon Pharma, which supports fat loss without significant protein catabolism risk; users who are not prepared to taper the compound correctly and monitor thyroid markers post-cycle should not use T3, as improper discontinuation causes a rebound hypothyroid state that can impair recovery for weeks

T3 vs Alternatives

Combinations

Side Effects & Management

Monitoring

Taper & Recovery

T3 does not require SERMs or gonadotropins, but it does require a mandatory dose taper and a post-cycle thyroid recovery period. Stopping liothyronine abruptly causes a rapid drop in circulating T3 before the suppressed HPT axis can resume adequate endogenous production — producing a transient hypothyroid state with fatigue, cold sensitivity, weight rebound, and cognitive slowdown. A controlled taper over 10–15 days eliminates this risk by allowing endogenous thyroid function to gradually resume as exogenous dose decreases.

Practical Summary

T3 Dragon Pharma is a precise pharmacological tool for accelerating fat oxidation where standard caloric restriction has reached its practical ceiling — delivering measurable, sustained metabolic rate elevation across the full 4–8 week cycle without the receptor desensitization that limits catecholamine-based thermogenics. At 25 mcg per tablet the dose can be titrated precisely from a conservative starting point to the individual user's effective range. The compound demands discipline: a mandatory AAS base, daily heart rate monitoring, a controlled taper, and a verified thyroid recovery period before the next cycle. Within those boundaries, T3 remains one of the most consistently effective fat-loss tools available at steroidwarehouse.com for athletes in the final phase of contest prep or a structured cutting block.

References